SEC Form 4 · accession 0001127602-15-024865
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. · CRL
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
David Ross Smith
Officer — Corporate Executive VP & CFO
Period of report
Aug 12, 2015
Accepted (ET)
Aug 13, 2015 · 4:07 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001100682
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Aug 12, 2015 | A | 3,026 | $0.00 | A | 7,537 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Options (Right to Buy)F2 | $76.12 | Aug 12, 2015 | A | 4,995 | A | Aug 12, 2016 | Aug 12, 2020 | Common Stock | 4,995 | 4,995 | D |
Explanation of responses
- F1Consists of 3,026 unvested restricted stock units (RSUs) which vest as follows: 756 on 8/12/2016, 757 on 8/12/2017, 756 on 8/12/2018 and 757 shares on 8/12/2019. Each RSU represents a contingent right to receive one share of common stock.
- F2Stock options will vest as follows: 1,248 on 8/12/2016, 1,249 on 8/12/2017, 1,249 on 8/12/2018 and 1,249 on 8/12/2019.